Quantcast
Last updated on April 20, 2014 at 19:30 EDT

Latest dialysis Stories

2013-11-23 00:20:21

Cuts to Dialysis Medicare Reimbursement Put Care of Vulnerable Patients at Risk WASHINGTON, Nov. 22, 2013 /PRNewswire-USNewswire/ -- The Kidney Care Council (KCC) is concerned about the negative impact of the multiyear reduction in payment released today by the Centers for Medicare & Medicaid Services (CMS) in the Medicare end-stage renal disease (ESRD) prospective payment system (PPS) Final Rule. "Dialysis providers are committed to providing the best quality care to all...

2013-11-22 20:22:53

Presby to Discuss Science and Chemistry Behind the Law DALLAS, Nov. 22, 2013 /PRNewswire/ -- The American Association for Justice (AAJ) has invited attorney Ellen Presby of the nationally recognized Nemeroff Law Firm to speak at the organization's Plaintiff-Only GranuFlo and Dialysis Products Seminar in New York City on Dec. 6, 2013. The seminar will offer legal developments, industry updates and trial techniques for cases involving the most widely-prescribed dry acid product in the...

2013-11-22 10:37:26

Patients receiving high intensity care when dialysis is initiated have shorter survival times and eventually need more intensive procedures Adults age 65 years and older represent half of the patients initiating chronic dialysis in the United States. Simple measures of the severity of an older kidney failure patient's illness when starting dialysis—such as whether dialysis was initiated in an inpatient setting, the length of the patient's hospital stay, and the use of other...

2013-11-21 23:19:59

The Firm is evaluating dialysis lawsuits on behalf of individuals who experienced life-threatening cardiac events, including heart attacks, strokes, and sudden cardiac death, allegedly due to GranuFlo and NaturaLyte dialysis concentrates. New York, New York (PRWEB) November 21, 2013 Hundreds of GranuFlo lawsuit (http://www.thegranuflolawsuit.com/) claims filed in the wake of last year’s recall for GranuFlo and NaturaLyte dialysis concentrates continue to move forward in a federal...

Investigational Bioengineered Vessel Shows Potential As Dialysis Graft
2013-11-21 06:37:46

Duke University Medical Center An investigational, man-made blood vessel used in vascular grafts for kidney dialysis patients may potentially show encouraging early results among study patients in Poland, according to preliminary data reported Wednesday by a researcher at Duke Medicine. Presented at the American Heart Association Scientific Sessions meeting in Dallas, the early findings of this interim patient data track 28 hemodialysis patients who received grafts using the...

2013-11-20 12:28:39

- The Humacyte investigational bioengineered blood vessel technology represents a research and development milestone in vascular tissue engineering. RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2013 /PRNewswire/ -- Humacyte, Inc., a pioneer in regenerative medicine, today announced the presentation of interim, first-in-human data from an ongoing, multi-center study in Poland, evaluating the company's investigational bioengineered blood vessel in hemodialysis patients with End-Stage...

2013-11-19 23:03:09

The Firm is evaluating dialysis lawsuits on behalf of patients who suffered heart attacks, strokes and other life-threatening cardiac problems, allegedly due to GranuFlo or NaturaLyte dialysis concentrates. New York, NY (PRWEB) November 19, 2013 GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) stemming from the 2012 recall of GranuFlo and NaturaLyte dialysis concentrates continue to mount in courts around the country, Bernstein Liebhard LLP reports. According to court documents, the...

2013-11-18 23:25:03

An increasing number of American patients are driving demand for dialysis devices and concentrates; a market value expected to reach $2 billion. Vancouver, BC (PRWEB) November 18, 2013 iData Research, the leading global authority in medical device market and pharmaceutical market research, has recently published a report for the U.S. dialysis devices and concentrates markets. The report estimates a combined market value of $1,650 million and growing. The total market is comprised of the...

2013-11-18 12:30:09

DaVita is the world's second largest dialysis provider BETHLEHEM, Pa., Nov. 18, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) announced today that it has entered into an agreement with DaVita Healthcare Partners for the supply of dialysis products. Under the new agreement, DaVita will purchase B.Braun Dialog+ dialysis equipment and associated disposables to fill a portion of its product requirement. "We are very pleased to continue our business relationship with DaVita...

2013-11-17 23:01:26

RnRMarketResearch.com adds “Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018” to its store. As of 2013, North America (comprising the U.S. and Canada) holds the largest share of the global dialysis market. Dallas, Texas (PRWEB) November 17, 2013 The global dialysis market is broadly...